ISET® story - ISET® - Isolation by Size of Tumor cells

ISET®: a life commitment for improving the life of cancer patients.

The ISET® technology is the fruit of 20 years of research of Prof. Patrizia Paterlini-Bréchot and her team at the University Paris Descartes and INSERM (Institut National de la Santé et de la Recherche Médicale). Patrizia Paterlini-Bréchot is a Professor of Cellular and Molecular Biology at the University Paris Descartes in Paris, France and Hospital Practitioner at Assistance Publique-Hôpitaux de Paris. As an Oncologist and Hematologist, she and her team have studied cancer since 1982, and more specifically circulating tumor cells since 1995. The work of the team in fundamental and applied research led to the publication of high level scientific studies in the field of predictive oncology. Oncology is the science devoted to the study and treatment of cancer. Predictive Oncology is the branch of Oncology, which predicts how and when a patient has to be treated in order to better fight against cancer.

In 2000, the work of Prof. Patrizia Paterlini-Bréchot’s team led to the invention of the ISET® technology: the first and still unparalleled filtration method for isolation of the very rare Circulating Tumor Cells (CTC) from blood, allowing their diagnostic identification by cytopathology and their molecular characterization. Once these cells are diagnostically validated by cytopathology after isolation by the ISET® technology, they are referred to as CCC, Circulating Cancer Cells.

The ISET® technology promises to improve the span and quality of life of patients with cancer. Such a highly sensitive technology will allow for a non-invasive, reliable and predictive diagnostic, which will bring remarkable help to people around the world in their struggle against cancer and save millions of lives through the early diagnosis of invasive cancers.

First patent

Vertical filtration to isolate Circulating Tumor Cells (still incomplete at this point)

ISET® defined for the first time

ISET® technology first reported in the American Journal of Pathology by Professor Paterlini-Brechot’s team

Publication

Vona G. et al
Am J Pathol 2000 Jan;156(1):57-63.
ISET, Isolation by Size of Epithelial Tumor cells: a new method for isolation, immunomorphological and molecular characterization of circulating tumor cells

First patent family

Vertical blood filtration

Founding of Metagenex

First company founded to develop and commercialize the ISET® technology based on the exclusive licensing of patents belonging to the French public institutions University Paris Descartes, Assistance Publique Hôpitaux de Paris and INSERM.

Second patent family

NI-PND: Non-Invasive Prenatal Diagnosis

Publication

Vona G. et al
Am J Pathol, 2002 Jan;160(1):51-8.
Enrichment and genetic analyses of fetal cells circulating in the maternal blood by the ISET technique and single cell microdissection : a non-invasive tool for early prenatal diagnosis

Publication

Béroud C. et al
Lancet, 2003 Mar 22;361(9362):1013-4.
Prenatal diagnosis of Spinal Muscular Atrophy (SMA) by genetic analysis of circulating fetal cells

Publication

Vona G. et al
Hepatology 2004 Mar;39(3):792-7.
Impact of cytomorphological and molecular characterization of circulating tumor cells in patients with Primary Liver Cancer

Publication

Lelièvre L. et al
Int J Gynecol Cancer 2004 Mar-Apr;14(2):229-33.
Effect of laparoscopy versus laparotomy on circulating tumor cells using isolation by size of epithelial tumor cells

Production

Manufacturing of ISET® device and consumables

Third patent family

Vertical filtration, device and consumables

Fourth patent family

NI-PND (non invasive prenatal diagnosis) of cystic fibrosis

Development of scientific recognition

Publication

Pinzani P. et al
Hum Pathol. 2006 Jun;37(6):711-8.
Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdisection

Publication

Saker A. et al
Prenat Diagn. 2006 Oct;26(10):906-16.
Genetic characterization of circulating fetal cells allows non invasive prenatal diagnosis of cystic fibrosis (CF).

Publication

Paterlini-Bréchot P. et Benali N.
Cancer Lett. 2007 Aug 18;253(2):180-204
Circulating Tumor Cells (CTC) detection: Clinical impact and future directions

Rarecells SAS is born

Rarecells SAS is born and the team gets a US federal grant for oncology and a grant for NI-PND

Production

Manufacturing of Rarecells device and consumables and improvement of filters and buffers.

Award

Patrizia Paterlini-Brechot is awarded the prestigious AP-HP (Assistance Publique – Hôpitaux de Paris) award for NI-PND.

Publication

Pinzani P. et al
Melanoma Res. 2010 Aug;20(4):303-10.
Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression

Publication

Descamps V. et al
Arch Dermatol 2010 Oct;146(10):1156-7.
ISET device: a useful tool to answer some questions about the biologic behavior of melanocytic nevus cells

Publication

De Giorgi V. et al
J Invest Dermatol. 2010 Oct;130(10):2440-7 2010
Application of a filtration and isolation-by-size technique for the detection of criculating tumor cells in cutaneous melanoma. J Invest Dermatol

Publication

De Giorgi V. et al
Arch Dermatol. 2010 Oct;146(10):1120-4.
Circulating benign nevus cells detected by ISET technique: warning for melanoma molecular diagnosis.

Foundation

Foundation of Rarecells Holdings and Rarecells subsidiaries. Rarecells® and ISET ® trademarks are deposited.

Publication

Hofman V. et al
Am J Clin Pathol, 2011 Jan;135(1):146-56.
Cytopathologic Detection of Circulating Tumor Cells Using the Isolation by Size of Epithelial Tumor Cell Method.

Publication

Hofman V. et al
Clin Cancer Res 2011 Feb 15;17(4):827-35
Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker

Publication

Hou JM. et al
Am J Pathol, 2011 Mar;178(3):989-96.
Circulating Tumor Cells as a Window on Metastasis Biology in Lung Cancer

Publication

Eifler et al.
Cytometry Part B 2011, 80B: 100-111
Enrichment of circulating tumor cells from a large blood volume using leukapheresis and elutriation: Proof of concept.

Publication
Paterlini-Bréchot P.
Future Oncol. 2011 Jul;7(7):849-71.
Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy.

Publication
Farace et al.
Br J Cancer. 2011 Sep 6;105(6):847-53
A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas.

Publication
Hofman V. et al
Int J Cancer, 2011 Oct 1;129(7):1651-60
Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small cell lung carcinoma: Comparison of the efficacy of the CellSearch AssayTM and the isolation by size of epithelial tumor cell method

Publication
Lecharpentier et al.
Br J Cancer. 2011 Oct 25; 105(9): 1338–1341
Detection of circulating tumor cells with an hybrid (i.e. epithelial/mesenchymal) phenotype in patients with metastatic non-small celll lung cancer.

Publication
Khoja et al.
Br J Cancer. 2012 Jan 31; 106(3):508-16. Epub 2011 Dec 20
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker.

Publication
Hou et al.
J Clin Oncol. 2012 Feb 10;30(5):525-32, Epub 2012 Jan 17
Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.

Publication
Krebs et al.
J Thorac Oncol. 2012;7: 306–315
Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches

Publication
Hofman V. et al
Cytopathology 2012 Feb;23(1):30-8.
Morphological analysis of circulating tumor cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumor cell (ISET) method.

Fifth Patent family
Rare Cells extraction from biological fluids and multiplexing

Publication
Ilie. et all
Ann Oncol. 2012 Nov;23(11):2907-13, Epub 2012 Jun 26
ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma.

Publication
Hofman et al.
Journal of Investigative Dermatology (2013) 133, 1378–1381; published online 10 January 2013
Usefulness of Immunocytochemistry for the Detection of the BRAF V600E Mutation in Circulating Tumor Cells from Metastatic Melanoma Patients

R&D
Development of R&D for molecular theranostics

Publication
Pailler et al.
J Clin Oncol. 2013 Jun 20;31(18):2273-81
Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non–small-cell lung cancer.

Publication
Costa, D.
Journal of Clinical Oncology, 31(18) 2013: pp 2236-223
Identification of Somatic Genomic Alterations in Circulating Tumors Cells: Another Step Forward in Non–Small-Cell Lung Cancer?

Publication
Marchesi, V.
Nat Rev Clin Oncol. 2013 Jul;10(7):366.
Lung cancer: ALK status of NSCLC reflected in CTCs.

Publication
Ma, Y.C. et al
Technol Cancer Res Treat. 2013 Aug;12(4):295-309.
Recent Advances and Prospects in the Isolation by Size of Epithelial Tumor Cells (ISET) Methodology

Publication
Chinen et al.
J Thorac Dis. 2013 Oct; 5(5): 593–599
Cytokeratin-based CTC counting unrelated to clinical follow up.

Award
Patrizia Paterlini-Brechot is awarded the prestigious American society of cytopathology award for New Frontiers in Cytology.

Publication
Khoja L. et al
Melanoma Res. 2014 Feb;24(1):40-6.
Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma

Publication
Mazzini C. et al
Cancers (Basel) 2014 Feb 7;6(1):323-32.
Circulating Tumor Cells Detection and Counting in Uveal Melanomas by a Filtration-Based Method

Publication
Cummings J. et al
BMC Cancer 2014 Mar; 28;14:226.
Optimisation of an immunohistochemistry method for the determination of androgen receptor expression levels in circulating tumour cells.

Publication
Hofman V. et al
Curr Mol Med 2014 May; 14(4):440-56.
Detection of circulating tumor cells from lung cancer patients in the era of targeted therapy: promises, drawbacks and pitfalls.

Publication
Khoja et al.
Ann Oncol (2015) 26 (1): 33-39, first published online June 6, 2014
Circulating Tumor Cells As Tumor Biomarkers In Melanoma:Detection Methods And Clinical Relevance.

Publication
Morris KL. et al
Cancer Chemother Pharmacol 2014 June ; 74(2):323-32.
Circulating biomarkers in hepatocellular carcinoma.

Publication
Chinen LT. et al
Onco Targets Ther. 2014 Sep 16;7:1609-1617.
Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion.

Publication
LeBleu VS. et al
Nat Cell Biol. 2014 Oct;16(10):992-1003.
PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis

Publication
Ilie. et all
PLOS One. 2014 Oct 31;9(10) :e111597l
« Sentinel » Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease

Publication
Faugeroux et al.
Front Oncol. 2014; 4: 281, published online 2014 Nov 5
Clinical Utility of Circulating Tumor Cells in ALK-Positive Non-Small-Cell Lung Cancer

Publication
Paterlini-Bréchot
Cancer Microenviron. 2014 Dec;7(3):161-76
Circulating Tumor Cells: Who is the Killer?

Publication
Ismailova et al.
J Clin Med Kaz 2015; 1(35):15-20
Detection of Circulating Tumor cells by ISET and their molecular characterization for use as liquid biopsy.

Publication
Abdallah et al.
Int J Cancer. 2015 Sep 15;137(6):1397-405. Epub 2015 Mar 11
Thymidylate synthase expression in circulating tumor cells: a new tool to predict 5-fluorouracil resistance in metastatic colorectal cancer patients.

Publication
Pailler et al.
Ann Oncol. 2015 Jul;26(7):1408-15. Epub 2015 Apr 6
High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer.

Commercialization
ISET Blood Cytopathology available in France. (Paris)

Publication
Buim et al.
Cancer Biol Ther. 2015;16(9):1289-95. Epub 2015 Aug 7
Detection of KRAS mutations in circulating tumor cells from patients with metastatic colorectal cancer.

Publication
Hofman et al.
Cancer Cytopathol. 2016 Jun;124(6):380-7. Epub 2015 Nov 20
Detection and characterization of circulating tumor cells in lung cancer: Why and how?

Publication
Poruk et al.
Ann Surg. 2016 Jan 7. (Epub ahead of print)
Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.

Publication
Salvianti et al.
Front Mol Biosci. 2016 Jan 8, 2:76
Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma.

Publication
Hong et al.
Tumour Biol. 2016 May;37(5):5663-74. Epub 2016 Jan 13
Phenotype of circulating tumor cell: face-off between epithelial and mesenchymal masks.

Commercialization
ISET Blood Cytopathology is available in Italy. (Naples)

Publication
Long et al.
Cancer Med. 2016 Jun;5(6):1022-30. Epub 2016 Mar 6
High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness.

Publication
Abdallah et al.
Int J Cancer. 2016 Aug 15;139(4):890-8. Epub 2016 Apr 28
MRP1 expression in CTCs confers resistance to irinotecan-based chemotherapy in metastatic colorectal cancer.

Publication
Massard et al.
Oncotarget. 2016 Jul 4.(Epub ahead of print)
Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castrationresistant prostate cancer: a report from the PETRUS prospective study.

Publication
Pailler et al.
BMC Cancer. 2016 Jul 14;16(1):477
Method for semi-automated microscopy of filtration-enriched circulating tumor cells.

Publication
Poruk et al.
Clin Cancer Res, 2016 Oct 27, [Epubahead of print]
Circulating tumor cells expressing markers of tumor initiating cells predict poor survival and cancer recurrence in patients with pancreatic ductal adenocarcinoma

Publication
Williamnson et al.
Nat Commun. 2016 Nov 9;7:13322. doi: 10.1038/ncomms13322.
Vasculogenic mimicry in small cell lung cancer

Publication
Kallergie et al.
Cell Physiol Biochem 2016;40:411-419 doi: 10.1159/000452556
Evaluation of Isolation Methods for Circulating Tumor Cells (CTCs).

Publication
Souza e Silva et al.
Onco Targets Ther. 2016, Dec. 9: 7503–7513. doi: https://doi.org/10.2147/OTT.S115268
Early detection of poor outcome in patients with metastatic colorectal cancer: tumor kinetics evaluated by circulating tumor cells.

Publication
Laget et al.
PLoS ONE 12(1): e0169427. doi:10.1371/journal.pone.0169427 Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.

Publication
Ilie et al.
Oncotarget 2017 Feb 15. doi:10.18632/oncotarget.15345 [Epub ahead of print] Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients.

Publication
Pailler et al.
Cancer Res 77(9) May 1, 2017. doi: 10.1158/0008-5472.CAN-16-3072 Circulating Tumor Cells with Aberrant ALK Copy Number Predict Progression-Free Survival during Crizotinib Treatment in ALK-Rearranged Non–Small Cell Lung Cancer Patients

Publication
Matikas et al.
Translational Oncology 2017 June 26; 10: 693-698. Detection of KRAS Exon 2 Mutations in Circulating Tumor Cells Isolated by the ISET System from Patients with RAS Wild Type Metastatic Colorectal Cancer.

Publication
Corassa et al.
Applied Cancer Research 201737:12 Circulating tumor cells as a new and additional approach to follow-up patients with serous low-grade ovarian adenocarcinoma – a case report and review of the literature

Publication
Poruk et al.
Pancreas 2017;46: 943–947. Circulating Epithelial Cells in Intraductal Papillary Mucinous Neoplasms and Cystic Pancreatic Lesions.

Publication
Fanelli et al.
Head & Neck 2017 1:10. Evaluation of incidence, significance, and prognostic role of circulating tumor microemboli and transforming growth factor-b receptor I in head and neck cancer.

Publication
Ried et al.
Asian Pacific Journal of Cancer Prevention 2017 Aug 27; 18(8):2275-2285. Screening for Circulating Tumour Cells Allows Early Detection of Cancer and Monitoring of Treatment Effectiveness: An Observational Study

Publication
Ilie et al.
Annals of Oncology 2017 Oct 09; Epub Detection of PD-L1 in circulating tumor cells and white blood cells from patients with advanced non-small cell lung cancer.

Publication
Leroy et al.
BMJ Open 2017, Oct 05. doi:10.1136/bmjopen-2017-018884 Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France.

Publication
Van der Toom et al.
The Prostate 2017;1–8, Dec 7. doi:10.1002/pros.23474. Analogous detection of circulating tumor cells using the AccuCyte®—CyteFinder® system and ISET system in patients with locally advanced and metastatic prostate cancer.

Publication
Kallergi et al.
Ther Adv Med Oncol 2018, 10: 1–11 doi:10.1177/1758834017750121 Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer

Publication
Braun et al.
Cancer Biol Ther 2018 Feb, Epub doi:10.1080/15384047.2018.1433498 EGFR Expression in Circulating Tumor Cells from High-Grade Metastatic Sarcomas.

Publication
Ilie et al.
Clin Chem Lab Med 2018 Feb, Epub doi: 10.1515/cclm-2017-0764
Use of circulating tumor cells in prospective clinical trials for NSCLC patients - standardization of the pre-analytical conditions

Publication
Diaz et al.
Applied Cancer Research (2018) 38:8
Circulating tumor cells as marker of poor prognosis in metastatic lung cancer: a pilot study

Publication
Guibert N. et al
Lung Cancer 120 (2018) 108–112.
PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab

Publication
Broncy et al.
Oncotarget 2018 Apr 13; 9(28):20058-20074.
Single-cell genetic analysis validates cytopathological identification of circulating cancer cells in patients with clear cell renal cell carcinoma

Publication
Kallergi et al.
Breast Cancer Res 2018, 20:6
Evaluation of α-tubulin, detyrosinated α-tubulin, and vimentin in CTCs: identification of the interaction between CTCs and blood cells through cytoskeletal elements.

Publication
Messaritakis et al.
Cancer Chemother Pharmacol 2018
Prognostic significance of CEACAM5mRNA-positive circulating tumor cells in patients with metastatic colorectal cancer.

Publication
Broncy et al.
J Lab Precis Med 2018;3:91.
Cancer-associated circulating atypical cells with both epithelial and macrophage-specific markers

Publication
Faugeroux et al.
European urology oncology (2019).
An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer.

Publication
Jonathan Benzaquen, Jacques Boutros, Charles Marquette, Hervé Delingetteand Paul Hofman.
Cancer 2019 Feb12;11(2). pii: E212. doi: 10.3390/cancers11020212.
Lung Cancer Screening, Towards a Multidimensional approach: why and how?

Publication
Abdallah E. A. et al.
The Oncologist2019;24:1–10
The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.

Publication
Gasparini-Junior et al.
ABCD. 2019. doi: 10.1590/0102-672020190001e1433
Evaluating MMP-2 and TGFβ-RI expression in circulating tumor cells of pancreatic cancer patients and their correlation with clinical evolution.

Publication
Kotsakis et al.
Ther Adv Med Oncol. 2019
CD8 + PD-1 + T-cells and PD-L1 + circulating tumor cells in chemotherapy-naïve non-small cell lung cancer: towards their clinical relevance?

Publication
Troncarelli Flores B.C. et al
Cells 2019, 8(7), 641;
Molecular and Kinetic Analyses of Circulating Tumor Cells as Predictive Markers of Treatment Response in Locally Advanced Rectal Cancer Patients.

Publication
Faugeroux V. et al
Eur Urol Oncol (2019)
An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer

Publication
Pailler E. et al
Clin Cancer Res 2019;25:6671–82
Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK-Rearranged Non–Small-Cell Lung Cancer

Publication
Monterisi S.. et al
Am J Nucl Med Mol Imaging 2019;9(6):282-295
Preliminary data on circulating tumor cells in metastatic NSCLC patients candidate to immunotherapy

Publication
Castello A., et al
Cancers 2020, 12(2), 487
Circulating Tumor Cells and metabolic parameters in NSCLC patients treated with checkpoint inhibitors.

Publication
Tamminga M., et al
Cancers 2020, 12(4), 896.
Detection of Circulating Tumor Cells in the diagnostic leukapheresis product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch® and ISET.

Publication
Ried K., et al
Front. Oncol. 10:582
New Screening Test Improves Detection of Prostate Cancer Using Circulating Tumor Cells and Prostate-Specific Markers.

Publication
Yu J., et al
Cancer Letters 493 (2020) 245–253
Pancreatic circulating tumor cell detection by targeted single-cell next-generation sequencing.

Publication
Yin L., et al
Clin Cancer Res February 1 2021 (27) (3) 740-748
Improved Assessment of Response Status in Patients with Pancreatic Cancer Treated with Neoadjuvant Therapy using Somatic Mutations and Liquid Biopsy Analysis.

Publication
Abdallah E.A., et al.
Transl Oncol. 2021
A higher platelet-to-lymphocyte ratio is prevalent in the presence of circulating tumor microemboli and is a potential prognostic factor for non-metastatic colon cancer.

Publication
Ntzifa A, et al.
Scientific Reports, 2021
Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients.

Publication
Ilie M., et al.
Journal of Thoracic Oncology (2021)
Prospective multi-center validation of the detection of ALK rearrangements of circulating tumor cells for non-invasive longitudinal management of patients with advanced non-small cell lung cancer.

Publication
Guedes de Castro D, et al.
Advances in Radiation Oncology, 2021
Prospective assessment of the association between circulating tumor cells and control of brain disease after focal radiotherapy of breast cancer brain metastases.

Publication
Silva VS. et al.
Diagnostics, 2021
Baseline and Kinetic Circulating Tumor Cell Counts Are Prognostic Factors in a Prospective Study of Metastatic Colorectal Cancer.

Publication
Silva VS. et al.
Cells, 2021
Molecular and Dynamic Evaluation of Proteins Related to Resistance to Neoadjuvant Treatment with Chemoradiotherapy in Circulating Tumor Cells of Patients with Locally Advanced Rectal Cancer

Publication
Fina E. et al.
Cancers, 2021
Subpopulations of Circulating Cells with Morphological Features of Malignancy Are Preoperatively Detected and Have Differential Prognostic Significance in Non-Small Cell Lung Cancer

Publication
Braun et al.
Front Oncol, 2021
Circulating Tumor Cells in Desmoid Tumors: New Perspectives.

Publication
Bueno De Oliveira et al.
Oral Oncology, 2021
Prognostic impact and potential predictive role of baseline circulating tumor cells in locally advanced head and neck squamous cell carcinoma.

Publication
Garrido et al.
Life, 2022
Predictive Value of Circulating Tumor Cells Detected by ISET® in Patients with Non-Metastatic Prostate Cancer Undergoing Radical Prostatectomy

Publication
Katsarou et al.
Journal of Personal Med
Detyrosinated α-Tubulin, Vimentin and PD-L1 in Circulating Tumor Cells (CTCs) Isolated from Non-Small Cell Lung Cancer (NSCLC) Patients.

Publication
Tarazona et al.

Mir-203a-3p And Mmp-2 Proteins Are Highly Expressed In Circulating Tumor Cells From Patients With Pancreatic Carcinoma. Arquivos Brasileiros de Cirurgia Digestiva (Brazilian archives of digestive surgery) : ABCD Arq Bras Cir Dig 2021;34(4):e1628.

Publication
Kallergi et al.
Cancers 2022
Effect of Osimertinib on CTCs and ctDNA in EGFR Mutant Non-Small Cell Lung Cancer Patients: The Prognostic Relevance of Liquid Biopsy

Publication
De Castro et al.
Cancers 2022
Heterogeneity of HER2 Expression in Circulating Tumor Cells of Patients with Breast Cancer Brain Metastases and Impact on Brain Disease Control.

Publication
Pignataro et al.
Brazilian Journal of Oncology 2022
Is platelet-lymphocyte ratio (PLR) a predictor of thrombosis and together with circulating tumor cells capable to determine recurrence-free survival in patients with gastric cancer?

Publication
Pantazaka et al.
Biomedicines 2022
PD-L1/pS6 in Circulating Tumor Cells (CTCs) during Osimertinib Treatment in Patients with Non-Small Cell Lung Cancer (NSCLC)

Publication
Javed et al.
Annals of Surgery 2022
A Delay in Adjuvant Therapy Is Associated With Worse Prognosis Only in Patients With Transitional Circulating Tumor Cells After Resection of Pancreatic Ductal Adenocarcinoma

Publication
Carreta Ruano et al.
Int. J. Mol. Sci. 2022
Fusion Cell Markers in Circulating Tumor Cells from Patients with High-Grade Ovarian Serous Carcinoma

Publication
Roumeliotou et al.
Cancers 2022
Phenotypic Characterization of Circulating Tumor Cells Isolated from Non-Small and Small Cell Lung Cancer Patients.

Publication
Carreta Ruano et al.
Pathology - Research and Practice, 2023
HPV virus and biomarkers of resistance to chemoradiation in circulating tumor cells from patients with squamous cell carcinoma of the anus

Publication
Javed et al.
Annals of Surgery 2023
Persistent Circulating Tumor Cells at 1 Year After Oncologic Resection Predict Late Recurrence in Pancreatic Cancer

Publication
Ali et al.
Medical Oncology 2023
Circulating cancer giant cells with unique characteristics frequently found in patients with myelodysplastic syndromes (MDS)

Publication
Garrido et al.
Cancers 2023
Polyploid giant cancer cells are frequently found in the urine of prostate cancer patients

Publication
Tariki et al.
Pathology - Research and Practice 253 (2024)
Circulating tumor cells as a predictor and prognostic tool for metastatic clear cell renal carcinoma: An immunocytochemistry and genomic analysis